BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Rosiglitazone
,
rs2300478
,
FGF21
,
Coagulation
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SEMA4D
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Soluble Sema4D cleaved from osteoclast precursors by TACE suppresses osteoblastogenesis.
Knockout of Sema4D alleviates liver fibrosis by suppressing AOX1 expression.
Anti-Semaphorin 4D Rescues Motor, Cognitive, and Respiratory Phenotypes in a Rett Syndrome Mouse Mod…
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodege…
Mediating immunosuppressive functions: a new perspective on the complex immunological properties of …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)
Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Sta…
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ